响马读paper

一个要求成员每月至少读一篇文献并打卡的学术交流社群

2023, Clinical and Translational Medicine. DOI: 10.1002/ctm2.1354
IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers
Yutao Liu, Yundi Zhang, Wenchuan Xie, Jing Zhao, Yiting Dong, Chunwei Xu, Yanan Wang, Man Li, Guoqiang Wang, Xin Zhu, Wenxian Wang, Kequan Lin, Huafei Lu, Yusheng Han, Leo Li, Jianchun Duan, Shangli Cai, Jie Wang, Zhijie Wang
Abstract:
="1.0" ?>


376493192023090120230928
2001-13261392023SepClinical and translational medicineClin Transl MedIMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers.e1354e1354e135410.1002/ctm2.1354LiuYutaoYState Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ZhangYundiYCAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.XieWenchuanWBurning Rock Biotech, Guangdong, China.ZhaoJingJBurning Rock Biotech, Guangdong, China.DongYitingYCAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.XuChunweiCInstitute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Zhejiang, China.WangYananYBurning Rock Biotech, Guangdong, China.LiManMCAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.WangGuoqiangGBurning Rock Biotech, Guangdong, China.ZhuXinXBurning Rock Biotech, Guangdong, China.WangWenxianWDepartment of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang, China.LinKequanKBurning Rock Biotech, Guangdong, China.LuHuafeiHBurning Rock Biotech, Guangdong, China.HanYushengYBurning Rock Biotech, Guangdong, China.LiLeoLBurning Rock Biotech, Guangdong, China.DuanJianchunJCAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.CaiShangliSBurning Rock Biotech, Guangdong, China.WangJieJCAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.WangZhijieZ0000-0002-7722-4956CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.engJournal ArticleResearch Support, Non-U.S. Gov't
United StatesClin Transl Med1015979712001-13260BiomarkersIMHumansPrognosisNeoplasmsdiagnosistherapyImmunotherapyBiomarkersThe authors declare they have no conflicts of interest.
202371920236820237242023916432023831642202383121ppublish37649319PMC1046857810.1002/ctm2.1354Lin A, Qi C, Wei T, et al. CAMOIP: a web server for comprehensive analysis on multi‐omics of immunotherapy in pan‐cancer. Brief Bioinform. 2022;23(3):bbac129.35395670Yang J, Zhao S, Wang J, et al. A pan‐cancer immunogenomic atlas for immune checkpoint blockade immunotherapy. Cancer Res. 2021;82(4):539‐542.PMC918923734903605Eddy JA, Thorsson V, Lamb AE, et al. CRI iAtlas: an interactive portal for immuno‐oncology research. F1000Res. 2020;9:1028.PMC765872733214875Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401‐404.PMC395603722588877Zhang F, Wang J, Xu Y, et al. Co‐occurring genomic alterations and immunotherapy efficacy in NSCLC. NPJ Precis Oncol. 2022;6(1):4.PMC876644235042953Braun DA, Ishii Y, Walsh AM, et al. Clinical validation of PBRM1 alterations as a marker of immune checkpoint inhibitor response in renal cell carcinoma. JAMA Oncol. 2019;5(11):1631‐1633.PMC673541131486842Wang Z, Duan J, Wang G, et al. Allele frequency‐adjusted blood‐based tumor mutational burden as a predictor of overall survival for patients with NSCLC treated with PD‐L1 inhibitors. J Thorac Oncol. 2020;15(4):556‐567.31843683Ravi A, Hellmann MD, Arniella MB, et al. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non‐small cell lung cancer. Nat Genet. 2023;55(5):807‐819.PMC1018194337024582Skoulidis F, Goldberg ME, Greenawalt DM, et al. STK11/LKB1 mutations and PD‐1 inhibitor resistance in KRAS‐mutant lung adenocarcinoma. Cancer Discov. 2018;8(7):822‐835.PMC603043329773717Wang X, Mi X, Li T, et al. Hyperprogressive disease after immune checkpoint inhibitor therapy in a patient with non‑small cell lung cancer who harbors a TGFBR2 mutation: a case report. Exp Ther Med. 2023;25(5):228.PMC1012680237114179
2023-11-30 23:39:00
#paper doi: 10.1002/ctm2.1354 IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers 这是一篇临床转化医学的数据库的文章,作者来自燃石、中国国家肿瘤中心等单位。数据库纳入了23000+样品、覆盖37种肿瘤,数据来源包括公共数据库、文献来源的数据集以及作者自己收集的一系列数据。数据库的主旨是挖掘和分析影响肿瘤预后的生物标志物。数据库功能还是比较多的,与既有的数据库相比更加灵活和细化,操作比较简便和直观,界面简洁一目了然,使用者可快速执行感兴趣的操作,提高分析效率。
TOP